|
0 Companies |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
5 News |
|
- Trial completion: FAIR-AD;PHRN08-VC / FAIR AD: FluoroAv45 Imaging Research-in Alzheimer's Disease (clinicaltrials.gov) - Feb 8, 2016
P2, N=54, Completed, Sponsor: University Hospital, Tours
Recruiting --> Completed
- | Biomarker, Trial completion, Trial primary completion date: Olfactory Neuroepithelial Tissue of Alzheimer Disease (clinicaltrials.gov) - May 27, 2015
P=N/A, N=40, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Sep 2014 --> Dec 2014
- New P1/2 trial: Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F) (clinicaltrials.gov) - May 18, 2014
P1/2, N=30, Terminated, Sponsor: Seoul National University Hospital
- Biomarker: Olfactory Neuroepithelial Tissue of Alzheimer Disease (clinicaltrials.gov) - Apr 30, 2014
P=N/A, N=40, Recruiting, Sponsor: Seoul National University Hospital
- Trial termination: [18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002) (clinicaltrials.gov) - Jun 6, 2012
P1, N=20, Terminated, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed | Trial primary completion date: Sep 2014 --> Dec 2014 Active, not recruiting --> Terminated